Status:
UNKNOWN
Prediction of Pseudophakodonesis of Intraocular Lenses
Lead Sponsor:
Prim. Prof. Dr. Oliver Findl, MBA
Conditions:
Cataract
Eligibility:
All Genders
21-105 years
Phase:
NA
Brief Summary
Compare visual acuity of patients after cataract surgery with implantation of an IOL clinical outcome measure in eyes with and without pseudoexfoliation syndrome or history of ocular trauma.
Detailed Description
Cataract surgery ist the most often performed surgery worldwide and with increasing number of patients undergoing surgery, patients' expectations concerning postoperative optical outcomes are growing....
Eligibility Criteria
Inclusion
- Cataract with the indication for surgery (decrease in visual acuity, blurred vision or glare ) for both groups (study and control group)
- Age 18 and older
- Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant
- Written informed consent
- Pseudoexfoliation syndrome or history of blunt ocular trauma - for the study group
Exclusion
- Pseudoexfoliation syndrome or history of blunt ocular trauma - for the control group
- History of penetrating ocular trauma
- Relevant other ophthalmic diseases that could affect corneal transparency or the ability for fixation
- Any relevant ophthalmic disease leading to limited visual acuity prognosis after cataract surgery
- In case of pregnancy (pregnancy test will be taken preoperatively in women of reproductive age)
Key Trial Info
Start Date :
May 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03751462
Start Date
May 1 2018
End Date
December 1 2019
Last Update
November 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vienna Institute for Research in Ocular Surgery (VIROS)
Vienna, Austria, 1140